Cargando…

Clinical value of AKR1B10 in hepatocellular carcinoma: A systematic review and meta-analysis

BACKGROUND: To evaluate the clinical value of Aldo-keto reductase family 1 member B10 (AKR1B10) in the diagnosis and prognosis of hepatocellular carcinoma (HCC). METHODS: A search of the PubMed, China Biology Medicine, Cochrane, and Embase databases was performed to conduct meta-analyses to evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Zixiang, Pei, Yinxuan, Li, Weiwei, Zhang, Jingxiao, Liu, Jinlong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803170/ https://www.ncbi.nlm.nih.gov/pubmed/36584078 http://dx.doi.org/10.1371/journal.pone.0279591

Ejemplares similares

Successful conversion therapy for unresectable hepatocellular carcinoma is getting closer: A systematic review and meta-analysis
por: Pei, Yinxuan, et al.
Publicado: (2022)

Efficacy of transarterial chemoembolization monotherapy or combination conversion therapy in unresectable hepatocellular carcinoma: A systematic review and meta-analysis
por: Li, Weiwei, et al.
Publicado: (2022)

Long term prophylactic anticoagulation for portal vein thrombosis after splenectomy: A systematic review and meta-analysis
por: Liao, Zheng, et al.
Publicado: (2023)

Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma
por: DiStefano, Johanna K., et al.
Publicado: (2019)

Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma
por: Zhu, Pengfei, et al.
Publicado: (2021)

AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021)

Expression of the Aldo-Ketoreductases AKR1B1 and AKR1B10 in Human Cancers
por: Laffin, Brian, et al.
Publicado: (2012)

AKR1B10 in gastrointestinal diseases
por: Shen, Yi, et al.
Publicado: (2015)

Fidarestat induces glycolysis of NK cells through decreasing AKR1B10 expression to inhibit hepatocellular carcinoma
por: Wu, Tiangen, et al.
Publicado: (2021)

The expression and significance of AKR1B10 in laryngeal squamous cell carcinoma
por: Liu, Jixuan, et al.
Publicado: (2021)

The Role of AKR1B10 in Physiology and Pathophysiology
por: Endo, Satoshi, et al.
Publicado: (2021)

Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication
por: Murata, Ayato, et al.
Publicado: (2016)

AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathway
por: Tian, Ke, et al.
Publicado: (2023)

Immunohistochemistry Detects Increased Expression of Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) in Early-Stage Hepatocellular Carcinoma
por: Han, Chao, et al.
Publicado: (2018)

Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) overexpression in tumors predicts worse overall survival in hepatocellular carcinoma
por: Shi, Jia, et al.
Publicado: (2019)

Prognostic value of aldo-keto reductase family 1 member B10 (AKR1B10) in digestive system cancers: A meta-analysis
por: Liu, Rongqiang, et al.
Publicado: (2021)

In-silico Investigations of quinine and quinidine as potential Inhibitors of AKR1B1 and AKR1B10: Functional and structural characterization
por: Ejaz, Syeda Abida, et al.
Publicado: (2022)

High expression of AKR1B10 predicts low risk of early tumor recurrence in patients with hepatitis B virus-related hepatocellular carcinoma
por: Wang, Yan-Yan, et al.
Publicado: (2017)

Overexpression and oncogenic function of aldo-keto reductase family 1B10 (AKR1B10) in pancreatic carcinoma
por: Chung, Yeon Tae, et al.
Publicado: (2012)

AKR1B10 Inhibitor Epalrestat Facilitates Sorafenib-Induced Apoptosis and Autophagy Via Targeting the mTOR Pathway in Hepatocellular Carcinoma
por: Geng, Nan, et al.
Publicado: (2020)

Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012)

AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma
por: Gao, Cheng, et al.
Publicado: (2023)

The effect of neutrophil extracellular traps in venous thrombosis
por: Li, Weiwei, et al.
Publicado: (2023)

Pseudogene AKR1B10P1 enhances tumorigenicity and regulates epithelial‐mesenchymal transition in hepatocellular carcinoma via stabilizing SOX4
por: Hao, Fengjie, et al.
Publicado: (2020)

Genetic variants in AKR1B10 associate with human eating behavior
por: Rohde, Kerstin, et al.
Publicado: (2015)

Prognostic significance of AKR1B10 in patients with resected lung adenocarcinoma
por: Hung, Jung‐Jyh, et al.
Publicado: (2018)

Biostatistics mining associated method identifies AKR1B10 enhancing hepatocellular carcinoma cell growth and degenerated by miR-383-5p
por: Wang, Junqing, et al.
Publicado: (2018)

AKR1B10 expression predicts response of gastric cancer to neoadjuvant chemotherapy
por: Ahmed, Syed Minhaj Uddin, et al.
Publicado: (2019)

AKR1B10 expression in benign prostatic hyperplasia and its related mechanism
por: Xu, Wenjing, et al.
Publicado: (2021)

Regulation Network and Prognostic Significance of Aldo-Keto Reductase (AKR) Superfamily Genes in Hepatocellular Carcinoma
por: Dai, Tianxing, et al.
Publicado: (2021)

AKR1B10 confers resistance to radiotherapy via FFA/TLR4/NF-κB axis in nasopharyngeal carcinoma
por: Liu, Xiangting, et al.
Publicado: (2021)

Prognostic value of des-γ-carboxy prothrombin in patients with hepatocellular carcinoma treated with transarterial chemotherapy: A systematic review and meta-analysis
por: Yang, Ming, et al.
Publicado: (2019)

FNDC5 and AKR1B10 inhibit the proliferation and metastasis of adrenocortical carcinoma cells by regulating AMPK/mTOR pathway
por: Chen, Danyan, et al.
Publicado: (2023)

Potential of AKR1B10 as a Biomarker and Therapeutic Target in Type 2 Leprosy Reaction
por: Soares, Cleverson T., et al.
Publicado: (2018)

Knockdown of AKR1C3 Promoted Sorafenib Sensitivity Through Inhibiting the Phosphorylation of AKT in Hepatocellular Carcinoma
por: Zheng, Jia, et al.
Publicado: (2022)

Prognostic value of SPARC in hepatocellular carcinoma: A systematic review and meta-analysis
por: Yang, Xiaoyu, et al.
Publicado: (2022)

AKR1B10 promotes breast cancer cell migration and invasion via activation of ERK signaling
por: Li, Jia, et al.
Publicado: (2017)

AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transition
por: Shao, Xinyu, et al.
Publicado: (2021)

AKR1B10 as a Potential Novel Serum Biomarker for Breast Cancer: A Pilot Study
por: Cao, Zhe, et al.
Publicado: (2022)

Overexpression of AKR1B10 Predicts Poor Prognosis in Gastric Cancer Patients Undergoing Surgical Resection
por: Liu, Yu-Yin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r370a4l8lbv7th41mm950ucvdh